Human Genome (HGSI) Second Successful Trial Sets Stage For Benlysta Approval
Tweet Send to a Friend
Human Genome Sciences Inc. (Nasdaq: HGSI) stock is soaring, up nearly 35 percent in early market trading, after announcing the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
